From: Epigenetic abnormalities in myeloproliferative neoplasms: a target for novel therapeutic strategies
Gene | Abbreviation | MPN subtype | Reference |
---|---|---|---|
Calcitonin A | CALCA | ET, PV, PMF | Ihalainen et al. (1994) |
V-abl Abelson murine leukemia viral oncogene homolog 1 | ABL1 | ET, PV, PMF | Aviram et al. (2003) |
Cyclin-dependent kinase inhibitor 2A | p14 ARF | CML | Nagy et al. (2003); Kumagai et al. (2005); Jost et al. (2007) |
p16INK4a | CML | ||
Cyclin-dependent kinase inhibitor 2b | p15INK4b | MF-BP | Wang et al. (2002) |
Secreted Frizzled-related protein 1 | SFRP1 | CML | Bennemann et al. (2010); Pehlivan et al. (2009) |
Secreted Frizzled-related protein 2 | SFRP2 | ET, PV, PMF | Bennemann et al. (2010) |
Wnt inhibitory factor-1 | WIF-1 | ET, PV, PMF | Suzuki et al. (2007) |
Suppressor of cytokine signaling 1 | SOCS1 | ET, PV, PMF, MF-BP | |
Suppressor of cytokine signaling 3 | SOCS3 | PMF | |
Polycythemia rubra vera protein 1 | PRV1 | ET, PV | Jelinek et al. (2007) |
C-X-C chemokine receptor type 4 | CXCR4 | PMF | Bogani et al. (2008) |
Retinoic acid receptor beta 2 | RARβ2* | PMF |